TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35388113

Group type: EXPERIMENTAL
Intervention: Early endoscopy (EE)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-EE (control)
Number of subjects: 43
Study: 34309427

Group type: EXPERIMENTAL
Intervention: Subthreshold nanosecond laser (SNL) treatment
Number of subjects: 0
Study: 32628688

Group type: EXPERIMENTAL
Intervention: PATHway intervention (eHealth cardiac rehabilitation)
Number of subjects: 60
Study: 34657043

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care only (CON)
Number of subjects: 242
Study: 33139269

Group type: EXPERIMENTAL
Intervention: Follow-up colonoscopy at 1 and 3 years (2-examination group)
Number of subjects: 3926

Group type: COMPARATOR
Intervention: Follow-up colonoscopy at 3 years only (1-examination group)
Number of subjects: 3926
Study: 36482065

Group type: EXPERIMENTAL
Intervention: BREATHE intervention with educational sessions and 24 months of follow-up
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group continued usual care
Number of subjects: 108
Study: 34098827

Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 3

Group type: COMPARATOR
Intervention: Abemaciclib
Number of subjects: 3

Group type: COMPARATOR
Intervention: Palbociclib
Number of subjects: 3
Study: 32650760

Group type: EXPERIMENTAL
Intervention: CRSCE-based de-escalation training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine WPV management training
Number of subjects: 0
Study: 34852779

Group type: EXPERIMENTAL
Intervention: Needle-free system (Comfort-In™) with 0.3 mL anesthesia (2% lidocaine and 1/80000 epinephrine)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dental needle method with 0.3 mL anesthesia (2% lidocaine and 1/80000 epinephrine)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Needle-free system (Comfort-In™)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dental needle method
Number of subjects: 56
Study: 32066146

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (≤20 mg/wk)
Number of subjects: 4786

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4786
Study: 33954799

Group type: EXPERIMENTAL
Intervention: Excision (surgical method)
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Histopathological regression
Number of subjects: 584
Study: 33050671

Group type: EXPERIMENTAL
Intervention: randori training
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: uchi‐komi training
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: running training
Number of subjects: 61

Group type: COMPARATOR
Intervention: regular training (control)
Number of subjects: 61
Study: 35254665

Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical prostatectomy (RARP)
Number of subjects: 782

Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Both RARP and LRP
Number of subjects: 782
Study: 35761310

Group type: EXPERIMENTAL
Intervention: PTQ2 intervention (smoking cessation and alcohol abstinence intervention)
Number of subjects: 40
Study: 34584971

Group type: EXPERIMENTAL
Intervention: 1 L PEG+Asc
Number of subjects: 164

Group type: COMPARATOR
Intervention: PEG+SPMC
Number of subjects: 164
Study: 32197765

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BPO) applied 5 times
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34974493

Group type: EXPERIMENTAL
Intervention: 2/3 circumference, 1.5 cm wide mucosal resection of the gastric cardia (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 1/2 circumference, 1.5 cm wide mucosal resection of the gastric cardia (Group B)
Number of subjects: 32
Study: 32086190

Group type: EXPERIMENTAL
Intervention: Cranial ultrasound (CUS) images with a novel fully-automatic method for ventricle quantification and PHH outcome prediction
Number of subjects: 0
Study: 35848920

Group type: EXPERIMENTAL
Intervention: Computerised anaesthesia (QuickSleeper)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional syringe anaesthesia
Number of subjects: 100
Study: 32962934

Group type: EXPERIMENTAL
Intervention: Continuous remifentanil infusion (R)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intermittent fentanyl boluses (F)
Number of subjects: 116
Study: 32819467

Group type: EXPERIMENTAL
Intervention: Machine-learning model using signal-processed ECG, traditional ECG, and clinical features
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Machine-learning model
Number of subjects: 1202
Study: 33888536

Group type: EXPERIMENTAL
Intervention: Sit Less, Interact, Move More intervention
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (national physical activity recommendations)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall treatment effects between groups
Number of subjects: 106
Study: 33337491

Group type: EXPERIMENTAL
Intervention: Vida Sana intervention (culturally adapted lifestyle intervention with family-based orientation and 22 group sessions over 12 months, plus monthly emails for an additional 12 months)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Vida Sana intervention
Number of subjects: 191
Study: 34425776

Group type: EXPERIMENTAL
Intervention: SOX+B-mab
Number of subjects: 45

Group type: COMPARATOR
Intervention: SOX+C-mab
Number of subjects: 45
Study: 32588891

Group type: EXPERIMENTAL
Intervention: Access to the PTSD Clinicians Exchange website (intervention group)
Number of subjects: 605

Group type: COMPARATOR
Intervention: Newsletter-only control group
Number of subjects: 605
Study: 33586475

Group type: EXPERIMENTAL
Intervention: Custom-made foot orthoses
Number of subjects: 81

Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 81
Study: 33310698

Group type: EXPERIMENTAL
Intervention: Music therapy sessions (5 sessions, 2 weeks before the exam)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 125
Study: 33493393

Group type: EXPERIMENTAL
Intervention: BSV (Besifovir dipivoxil maleate)
Number of subjects: 197

Group type: COMPARATOR
Intervention: TDF (Tenofovir disoproxil fumarate) to BSV (Besifovir dipivoxil maleate) switch
Number of subjects: 197
Study: 32448177

Group type: EXPERIMENTAL
Intervention: Single goal (SG) high dietary fiber intervention (≥30 g/day) with snacks containing 10‐12 g of dietary fiber for the first 6 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard care (UC) group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single goal (SG) high dietary fiber intervention
Number of subjects: 12
Study: 35119492

Group type: EXPERIMENTAL
Intervention: Friedman placement (baseplate peg placed perpendicular to the Friedman axis)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Glenoid placement (baseplate peg placed parallel to the glenoid surface)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between sexes
Number of subjects: 44
Study: 33086239

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (0.08 mg/kg)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 191
Study: 35840305

Group type: EXPERIMENTAL
Intervention: dCBT-I + ER intervention through self-guided online platform and four videoconferencing therapy sessions
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: dCBT-I + ER intervention
Number of subjects: 156

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 156
Study: 33526026

Group type: EXPERIMENTAL
Intervention: JOBS Program Germany (intervention group)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Waiting control group (control)
Number of subjects: 1500
Study: 32780946

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine
Number of subjects: 227
Study: 35977807

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 34338136

Group type: EXPERIMENTAL
Intervention: 11 miRNA signature
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: miRNAs-based model
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: miRNAs expression in EC tissues
Number of subjects: 514
Study: 34059692

Group type: EXPERIMENTAL
Intervention: 125I particle implantation therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Whole-pelvic irradiation and cisplatin-based concurrent chemoradiation therapy (Control)
Number of subjects: 62
Study: 33378478

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) with passive self-ligating brackets
Number of subjects: 60

Group type: COMPARATOR
Intervention: Micro-osteoperforation (MOP) with conventional brackets
Number of subjects: 60
Study: 33461308

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4456

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4456

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKA)
Number of subjects: 4456
Study: 35344089

Group type: EXPERIMENTAL
Intervention: Standard position (300 µm pre- and post-anterior capsule)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Increased distance (400 µm pre- and post-anterior capsule)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Unsymmetrical distances (200 µm pre- and 400 µm post-anterior capsule)
Number of subjects: 113
Study: 34600245

Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 36320025

Group type: EXPERIMENTAL
Intervention: Passive music intervention (60 min per day)
Number of subjects: 44
Study: 34537339

Group type: EXPERIMENTAL
Intervention: Single-shot interscalene nerve block (ISB)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Periarticular injection (PAI)
Number of subjects: 77
Study: 35165387

Group type: EXPERIMENTAL
Intervention: Pre-infection plasma cytokine expression
Number of subjects: 69
Study: 33143755

Group type: EXPERIMENTAL
Intervention: Fish oil + placebo
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Probiotics + placebo
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Fish oil + probiotics
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo + placebo
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: GDM (gestational diabetes)
Number of subjects: 439
Study: 32907904

Group type: EXPERIMENTAL
Intervention: Combination therapy of 10 mg elobixibat (EXB) and 9 g cholestyramine (CTM) powder
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 10 mg elobixibat (EXB) monotherapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 9 g cholestyramine (CTM) powder monotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 100
Study: 34009888

Group type: EXPERIMENTAL
Intervention: Mobile app CDST
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Print CDST
Number of subjects: 149

Group type: COMPARATOR
Intervention: No CDST
Number of subjects: 149
Study: 33002927

Group type: EXPERIMENTAL
Intervention: Clinical + TOF monitoring
Number of subjects: 77

Group type: COMPARATOR
Intervention: Clinical monitoring
Number of subjects: 77
Study: 35631137

Group type: EXPERIMENTAL
Intervention: LOW‐HIIT (14 min/session, 2 ×/week for 12 weeks)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 3‐RT (50 min/session, 2 ×/week for 12 weeks)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 1‐RT (15 min/session, 2 ×/week for 12 weeks)
Number of subjects: 106
Study: 33739852

Group type: EXPERIMENTAL
Intervention: Intensified pegaspargase (four additional doses at 3-week intervals during consolidation and interim maintenance)
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Standard COG low-intensity therapy (including two pegaspargase doses during induction and delayed intensification)
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Low-risk patients compared to standard-risk patients with identical therapy
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Overall survival (OS) for intensified pegaspargase
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Overall survival (OS) for standard COG therapy
Number of subjects: 1857
Study: 33031335

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) intervention for 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-intervention group (control)
Number of subjects: 68
Study: 35506299

Group type: EXPERIMENTAL
Intervention: Freeze-dried bone allograft (FDBA) combined with collagen membrane
Number of subjects: 48

Group type: COMPARATOR
Intervention: Autogenous bone chips plus deproteinized bovine bone material (DBBM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both interventions (FDBA and DBBM)
Number of subjects: 48
Study: 32921069

Group type: EXPERIMENTAL
Intervention: Aggressive metastasis-directed therapy (MDT) with surgery and/or hypofractionated image-guided radiation therapy (HIGRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDT for oligometastatic breast cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improved systemic therapies (targeted agents and immunotherapy)
Number of subjects: 0
Study: 32472141

Group type: EXPERIMENTAL
Intervention: Diet, Exercise, and Lifestyle interventions (IDEAL study)
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: IDEALPlus subset interventions (daily journals and body fat assessment)
Number of subjects: 920
Study: 35068224

Group type: EXPERIMENTAL
Intervention: Autologous blood injection (ABI)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dry-needling alone
Number of subjects: 90
Study: 33253933

Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor 23 (FGF23)
Number of subjects: 0
Study: 36151961

Group type: EXPERIMENTAL
Intervention: Combination of Foley's transcervical catheter and sublingual Misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sublingual Misoprostol alone
Number of subjects: 0
Study: 36269738

Group type: EXPERIMENTAL
Intervention: Web-based parenting program (e-learning program entitled 'Making a healthy deal with your child')
Number of subjects: 475

Group type: COMPARATOR
Intervention: Control condition (existing school-based overweight prevention program without the e-learning component)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Web-based parenting program
Number of subjects: 475
Study: 34166231

Group type: EXPERIMENTAL
Intervention: VRC01
Number of subjects: 12
Study: 36434080

Group type: EXPERIMENTAL
Intervention: Foliar Zn application
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Foliar Fe application
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Foliar Zn + Fe application
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 33944897

Group type: EXPERIMENTAL
Intervention: Interim 18F‐FDG‐PET after 2 cycles (I‐PET2)
Number of subjects: 1692

Group type: EXPERIMENTAL
Intervention: Interim 18F‐FDG‐PET after 4 cycles (I‐PET4)
Number of subjects: 1692

Group type: EXPERIMENTAL
Intervention: Interim 18F‐FDG‐PET after 3 cycles (I‐PET3)
Number of subjects: 1692

Group type: COMPARATOR
Intervention: Interim 18F‐FDG‐PET after 1 cycle (I‐PET1)
Number of subjects: 1692
Study: 32602362

Group type: EXPERIMENTAL
Intervention: Full version of the application 'Relieve my back' with evidence-based instructions and therapeutic exercises for LBP management
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo version of the application with instructions about nutrition
Number of subjects: 40
Study: 35296289

Group type: EXPERIMENTAL
Intervention: Information related to AstraZeneca's vaccine safety
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Information related to misinformation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Information related to individual health risks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Information related to public health risks
Number of subjects: 100
Study: 35234092

Group type: EXPERIMENTAL
Intervention: 2DR (bDRV 800 mg + dolutegravir 50 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 3DR (boosted darunavir + two NRTIs)
Number of subjects: 27
Study: 33021688

Group type: EXPERIMENTAL
Intervention: Near-focus magnification with second-generation narrow-band imaging (NF-NBI)
Number of subjects: 4523

Group type: COMPARATOR
Intervention: White-light imaging (WLI)
Number of subjects: 4523

Group type: COMPARATOR
Intervention: Second-generation narrow-band imaging (2G-NBI)
Number of subjects: 4523
Study: 616765640

Group type: EXPERIMENTAL
Intervention: Knee task
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Shoulder task
Number of subjects: 18

Group type: COMPARATOR
Intervention: Transfer task (after swapping models)
Number of subjects: 18
Study: 34554225

Group type: EXPERIMENTAL
Intervention: Urban forest intervention program
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Healthy eating
Number of subjects: 76
Study: 33031298

Group type: EXPERIMENTAL
Intervention: SUZY forceps
Number of subjects: 60

Group type: COMPARATOR
Intervention: Magill forceps
Number of subjects: 60
Study: 33166580

Group type: EXPERIMENTAL
Intervention: Corticosteroid and cyclophosphamide
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tacrolimus and rituximab
Number of subjects: 86
Study: 33399273

Group type: EXPERIMENTAL
Intervention: PBMNCs
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCCs
Number of subjects: 50
Study: 32452344

Group type: EXPERIMENTAL
Intervention: Baricitinib 4-mg once daily
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 36267016

Group type: EXPERIMENTAL
Intervention: Blended behavioral intervention (JASPER + EMT)
Number of subjects: 31
Study: 33998020

Group type: EXPERIMENTAL
Intervention: fGSH (face-to-face guided self-help)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: eGSH (email guided self-help)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Waiting List (control)
Number of subjects: 180
Study: 32299093

Group type: EXPERIMENTAL
Intervention: Presence of MDS‐associated phenotypic alterations (MDS‐PA) at diagnosis
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: MDS‐PA
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: MDS‐PA at diagnosis
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Dynamics of MDS‐PA after autologous transplant
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: MDS‐associated mutations after high-dose therapy
Number of subjects: 285
Study: 34674069

Group type: EXPERIMENTAL
Intervention: ICD‐10 codes for cirrhosis
Number of subjects: 1317

Group type: EXPERIMENTAL
Intervention: ICD‐10 codes for portal hypertensive complications
Number of subjects: 1317
Study: 33091934

Group type: EXPERIMENTAL
Intervention: Anorectal malformation (ARM) patients
Number of subjects: 817

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched individuals)
Number of subjects: 817
Study: 32801257

Group type: EXPERIMENTAL
Intervention: Split-dose (SPD) 2 L polyethylene glycol electrolyte solution, 1 L PEG between 8-9 pm the day before and 1 L PEG between 5-6 am on the day of colonoscopy.
Number of subjects: 295

Group type: COMPARATOR
Intervention: Single-dose (SID) 2 L polyethylene glycol electrolyte solution, 2 L PEG between 4-6 am on the day of colonoscopy.
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Split-dose (SPD) group
Number of subjects: 295

Group type: COMPARATOR
Intervention: Single-dose (SID) group
Number of subjects: 295
Study: 36061557

Group type: EXPERIMENTAL
Intervention: Percutaneous access endovascular repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cutdown access endovascular repair
Number of subjects: 0
Study: 34481095

Group type: EXPERIMENTAL
Intervention: 6-Hz tACS for 26.67 min daily for three days (Long Exposure Theta group)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 6-Hz tACS for 5.33 min daily (Short Exposure Theta group)
Number of subjects: 3

Group type: COMPARATOR
Intervention: 1-Hz tACS for 26.67 min (Control group)
Number of subjects: 3
Study: 35834196

Group type: EXPERIMENTAL
Intervention: Challenge-focused program (targeted toward high autonomous motivation)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Rewards-focused program (targeted toward low autonomous motivation)
Number of subjects: 68
Study: 32319870

Group type: EXPERIMENTAL
Intervention: Cognitive Filtering Efficiency (CFE) measured through ERP correlates during a delayed-match-to-sample task.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-Cognitive Filtering Efficiency (Low-CFE) individuals
Number of subjects: 0
Study: 35235653

Group type: EXPERIMENTAL
Intervention: Nucleoside reverse transcriptase inhibitor + integrase strand transfer inhibitor ART
Number of subjects: 4907

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 4907
Study: 32711578

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 186
Study: 35043578

Group type: EXPERIMENTAL
Intervention: Intracoronary autologous bone marrow-derived cells (BMCs)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 33685825

Group type: EXPERIMENTAL
Intervention: SUP with omeprazole
Number of subjects: 144

Group type: COMPARATOR
Intervention: No SUP (Control)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 144
Study: 35084948

Group type: EXPERIMENTAL
Intervention: Abemaciclib plus endocrine therapy (ET)
Number of subjects: 5807

Group type: EXPERIMENTAL
Intervention: Abemaciclib plus ET
Number of subjects: 5807

Group type: COMPARATOR
Intervention: Endocrine therapy (ET) alone
Number of subjects: 5807
Study: 32797376

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) followed by chemoradiotherapy (CRT) - TPF arm
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) followed by chemoradiotherapy (CRT) - PF arm
Number of subjects: 439

Group type: COMPARATOR
Intervention: Chemoradiotherapy (CRT) alone
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) followed by chemoradiotherapy (CRT) - TPF or PF arm
Number of subjects: 439
Study: 35577745

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Mucosamin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 71